Market Place
Sourcing Support
All News #Library
Sciences
Judge Award 30% Ongoing Royalty to Natera for MRD-Related Patents
09 Apr 2026 //
BUSINESSWIRE
Natera Announces Commercial Launch of Zenith Genomics
12 Mar 2026 //
BUSSINESSWIRE
Natera Initiates EDEN Study For Early Preeclampsia Risk
06 Feb 2026 //
BUSINESSWIRE
Prospera Advances Lung Transplant Care In Landmark Study
26 Jan 2026 //
BUSINESSWIRE
Natera Validates Latitude MRD Test For Colorectal Cancer
21 Jan 2026 //
BUSINESSWIRE
Natera`s Fetal Focus Sgnipt Chosen For Key Presentation At SMFM
20 Jan 2026 //
BUSINESSWIRE
Natera Launches 21-Gene Fetal NIPT Test
05 Jan 2026 //
BUSINESSWIRE
PALLAS Study: Signatera MRD Testing Enhances Prognosis
10 Dec 2025 //
BUSINESSWIRE
Natera Acquires Foresight Diagnostics
05 Dec 2025 //
BUSINESSWIRE
Natera Expands Fetal Focus NIPT to Include 20 Genes
31 Oct 2025 //
BUSINESSWIRE
Natera Introduce AI Model for Diagnostic & Therapeutic Innovation
22 Aug 2025 //
BUSINESSWIRE
Natera Tech Highlighted in 300+ Publications, Medicine Leadership
22 Aug 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.